Malignant Hyperthermia Association of the United States Daniel Massik Writing Award
Daniel Massik Writing Award given in August.
In order to promote awareness of MH and its various manifestations and to encourage continued study of the syndrome, Mr. George Massik, a founding member of MHAUS, has graciously offered to support a writers’ award. The Daniel Massik Fund at The Foundation for Jewish Philanthropies in Buffalo, NY was established by Mr. Massik in memory of his son who died from MH. This Award will provide a stipend of $1,500 to an anesthesia resident/fellow or an anesthesiologist who is within five years of ending his/her training to attend the annual meeting of the American Society of Anesthesiologists Meeting or, in special circumstances, another meeting of similar merit.
MH is an inherited disorder of muscle, which is “triggered” by commonly used anesthetic agents and may lead to death or disability. Early diagnosis and prompt treatment is the key to reducing morbidity and mortality related to MH. MH may occur at any time during an anesthetic whether in a hospital, ambulatory surgery center or an office-based setting. A large variety of programs have been developed by the scientific panel at MHAUS in order to increase awareness of the syndrome and its manifestations. These include procedure manuals for recognizing and treating MH applicable to the Hospital or to the Ambulatory Surgery Center and a variety of other publications.
The Award will be given to the primary author of the best manuscript concerning, malignant hyperthermia. The format may be a case report, literature review or original study.
The document should address a significant issue related to the problem of malignant hyperthermia.
Those participating must currently be a resident fellow in anesthesiology or an anesthesiologist who is within five years of ending his/her training.
The paper must be a minimum of 3 double-spaced typed pages and a maximum of 10 pages. Author’s CV should be included.
The paper must not be in any stage of publication.
Deadline for receipt of the manuscript in the MHAUS office is August 3.
The award will be presented at the annual MHAUS Recognition Reception at the Annual Meeting of the American Society of Anesthesiologists Annual Meeting.
The winner will be notified by August 31 to allow for coordination of travel plans.
For further information regarding the application process for this award, please contact the Malignant Hyperthermia Association of the United States (MHAUS), attention Gloria Artist, either via regular mail at P. O. Box 1069, Sherburne, NY 13460, via fax at 607-674-7910 or email at firstname.lastname@example.org.